In the clinical treatment of malignant tumors, antimetabolite agents have become one of the core components of chemotherapy regimens due to their strong targeting properties and well-defined mechanisms of action. These drugs mimic endogenous metabolic substances, interfere with ...Learn More

Chemotherapy remains one of the cornerstone approaches in cancer treatment. Among the various classes of chemotherapeutic agents, alkylating agents are widely used in clinical practice due to their ability to directly damage tumor cell DNA and inhibit cell proliferation. ...Learn More

Have you ever felt the weight of a cancer diagnosis, wondering if the next treatment will truly make a difference? The endless cycles of therapy, the fear of recurrence, the search for something more targeted and less burdensome—these are experiences shared by countless patients ...Learn More

By HongKong DengYue Medicine Picture this: A woman in her 50s wakes up each morning to the quiet fear of a fragile bone snapping during everyday activities like bending to tie her shoes or stepping off a curb. Or consider a patient battling advanced cancer, enduring cycles of ...Learn More

As an editor at Hong Kong DengYue Medicine contributing to MolecularCloud, I closely follow the dynamic landscape of global biopharma. In early 2026, one story stands out: RemeGen's RC148, a novel PD-1/VEGF bispecific antibody, secured a landmark exclusive licensing deal with ...Learn More